Evans Pharmaceuticals Private Limited - Charges

Every charge - open or closed - that lenders have registered against Evans Pharmaceuticals Private Limited, with the most recent activity at…

2002-09-05 Calicut, Kerala Active Unlisted Active Non-Compliant
View plans
EP Evans Pharmaceuticals Private Limited
Open charges
0
0.00
Closed charges
3
12.00 Lakh
Total
3
12.00 Lakh
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Canara Bank 1 10.00 Lakh
2 The Canara Bank 2 2.00 Lakh
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
90019998 The Canara Bank 27 Jul 2004 04 Sep 2004 03 Aug 2019 1.00 Lakh Closed
80007831 Canara Bank 27 Jan 2004 31 Jan 2013 03 Aug 2019 10.00 Lakh Closed
90019597 The Canara Bank 27 Jan 2004 - 03 Aug 2019 1.00 Lakh Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Evans Pharmaceuticals Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Evans Pharmaceuticals Private Limited (CIN: U51397KL2002PTC015629). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Evans Pharmaceuticals Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.